Authors:
LISSONI P
ARDIZZOIA A
BARNI S
BRIVIO F
TISI E
ROVELLI F
TANCINI G
MAESTRONI G
FUMAGALLI L
Citation: P. Lissoni et al., EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS, Oncology Reports, 2(6), 1995, pp. 1063-1068
Authors:
LISSONI P
BARNI S
TANCINI G
ARDIZZOIA A
TISI E
ANGELI M
RIZZI A
Citation: P. Lissoni et al., INTRACAVITARY THERAPY OF NEOPLASTIC EFFUSIONS WITH CYTOKINES - COMPARISON AMONG INTERFERON-ALPHA, INTERFERON-BETA AND INTERLEUKIN-2, Supportive care in cancer, 3(1), 1995, pp. 78-80
Authors:
LISSONI P
ROVELLI F
TISI E
BRIVIO F
ARDIZZOIA A
BARNI S
TANCINI G
SAUDELLI M
CESANA E
VIGANO MG
Citation: P. Lissoni et al., RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 146-149
Authors:
LISSONI P
BARNI S
TANCINI G
BRIVIO F
TISI E
ZUBELEWICZ B
BRACZKOWSKI R
Citation: P. Lissoni et al., ROLE OF THE PINEAL-GLAND IN THE CONTROL OF MACROPHAGE FUNCTIONS AND ITS POSSIBLE IMPLICATION IN CANCER - A STUDY OF INTERACTIONS BETWEEN TUMOR-NECROSIS-FACTOR-ALPHA AND THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 126-129
Authors:
LISSONI P
BARNI S
TANCINI G
ARDIZZOIA A
RICCI G
ALDEGHI R
BRIVIO F
TISI E
ROVELLI F
RESCALDANI R
QUADRO G
MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199
Authors:
LISSONI P
BARNI S
TISI E
ROVELLI F
PITTALIS S
RESCALDANI R
VIGORE L
BIONDI A
ARDIZZOIA A
TANCINI G
Citation: P. Lissoni et al., INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER, European journal of cancer, 29A(8), 1993, pp. 1127-1132
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
OLIVINI G
BRIVIO F
TISI E
TANCINI G
CHARACIEJUS D
KOTHARI L
Citation: P. Lissoni et al., CANCER-IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS ADMINISTRATION - POTENTIAL EFFICACY IN MOST SOLID TUMOR HISTOTYPES BY A CONCOMITANT TREATMENT WITH THE PINEAL HORMONE MELATONIN, Journal of biological regulators and homeostatic agents, 7(4), 1993, pp. 121-125
Authors:
LISSONI P
ARDIZZOIA A
TISI E
ROSSINI F
BARNI S
TANCINI G
CONTI A
MAESTRONI GJM
Citation: P. Lissoni et al., AMPLIFICATION OF EOSINOPHILIA BY MELATONIN DURING THE IMMUNOTHERAPY OF CANCER WITH INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 7(1), 1993, pp. 34-36